A Profile of Healthcare Professional Carsten Thiel
Carsten Thiel is a leading professional in the field of biotechnology. With his professional experience, he ahs been able to launch a number of well known medical products such as Stensiq, Prolia, Vectibix and Neulasta. Along with launching these products, Carsten also has much direct involvement in improving the lives of many patients. One of the keys to his approach to healthcare is his adherence to medical ethics. He emphasizes medical ethics whenever he makes decisions. With his ethical approach to medicine, Carsten Thiel has looked to change existing medical protocols and his proposed changes have helped provide more comprehensive care for patients as well as improving the provider patient relationship.
Originally from Berlin, Germany, Carsten Thiel established himself as a top student. He studied chemistry in Marburg and looked to continue his studies in England. He attended the University of Bristol in the southwestern United Kingdom. During his time as a student, Thiel studied other subjects such as biochemistry and organic chemistry. Carsten completed a Bachelor of Science degree in chemistry from the University of Bristol. Thiel would later attend Max Planck Institute for Biophysical Chemistry where he completed a doctorate degree in molecular biology.
After completing his educational programs, Carsten Thiel went on to begin his career and enter the workforce. He joined a company called Hoffman La Roshe which was a leading biotechnology firm. Thiel started out as a Communications and Product Manager where he used his scientific knowledge, innovative thinking and interpersonal skills to succeed. Shortly after joining the company, Carsten would then advance through the company where he would be offered the opportunity to hold a position in scientific marketing. Once he mastered a variety of roles in biochemistry, Thiel would then use his expertise to test products in the market and introduce them to the pharmaceutical sector.
Carsten Thiel’s: Facebook Page.